<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02937545</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00068552</org_study_id>
    <secondary_id>2R01GM081416-08A1</secondary_id>
    <nct_id>NCT02937545</nct_id>
  </id_info>
  <brief_title>Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting</brief_title>
  <official_title>Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of General Medical Sciences (NIGMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare patient use of and satisfaction with community&#xD;
      pharmacist-delivered pharmacogenetic (PGx) testing delivered along or as part of a medication&#xD;
      therapy management (MTM) service. Pharmacist and patient outcome measures will be collected&#xD;
      by surveys, interviews, and review of pharmacy records.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to investigate the delivery of pharmacogenetic (PGx) testing alone or in&#xD;
      combination with Medication Therapy Management (MTM) in the community pharmacy setting in&#xD;
      order to assess and compare the two delivery models. Using a clust randomized trial, these&#xD;
      effects of these two models will be compared. Pharmacist and patient outcome measures will be&#xD;
      collected by survey, interviews, and review of pharmacy records. The investigators intend to&#xD;
      compare the effect of PGx alone and PGx with MTM from the pharmacy perspective (to assess&#xD;
      impact on workflow/operations) and patient perspective (to assess acceptance of testing,&#xD;
      understanding of results, medication adherence, and overall satisfaction with delivery&#xD;
      model). In the PGx only arm, pharmacists will offer PGx testing to patients who are&#xD;
      prescribed one of the 10 eligible drugs (aripiprazole, carisoprodol, celecoxib, citalopram,&#xD;
      clopidogrel, metoprolol, nortriptyline, paroxetine, simvastatin, warfarin) and will return&#xD;
      results to the patient and physician with any recommendations for drug or dosage changes&#xD;
      based on results. In the PGx and MTM arm, pharmacists will offer PGx testing to patients&#xD;
      prescribed one of the 10 eligible drugs and provide two MTM sessions: one at the time of&#xD;
      testing, and one when results are returned. All patients will be surveyed before PGx testing&#xD;
      and 3 months after receiving results. Pharmacists will be surveyed prior to their&#xD;
      participation and following the conclusion of the study. Pharmacists will also conduct a&#xD;
      chart review of patients and document all interactions with enrolled patients and their&#xD;
      providers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 22, 2017</start_date>
  <completion_date type="Actual">September 10, 2019</completion_date>
  <primary_completion_date type="Actual">September 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Patient Participants' Acceptance of PGx Services Offered in Community Pharmacy Setting</measure>
    <time_frame>Post-study Survey (after test results received)</time_frame>
    <description>Post-Study Survey question: &quot;Now that you know your test results, would you have taken the test in the first place?&quot; (Response: 'would definitely' have taken the test)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Patient Participants Who Recalled All Test Results</measure>
    <time_frame>Post-study (after test results received)</time_frame>
    <description>Post-Study Survey Question: &quot;As best you can, please choose the result of your drug response test for the following genes&quot; (Response: Result selected for all 5 genes)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Patient Participants Who Considered Time With Pharmacist to be Worthwhile</measure>
    <time_frame>Post-study (after test results received)</time_frame>
    <description>Patient survey question - &quot;Did you feel your time spent with the pharmacist was worthwhile?&quot;. Reported as number of participants who selected answer choice &quot;Yes, definitely&quot;.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Patient Participants' With High Medication Adherence</measure>
    <time_frame>Baseline (prior to testing)</time_frame>
    <description>Pre-study (baseline) survey question: &quot;In the last 7 days, I took all doses as prescribed&quot; (Response: &quot;strongly agree&quot;)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Patient Participants With High Medication Adherence (Post-study)</measure>
    <time_frame>Post-Study (after test results received)</time_frame>
    <description>Post-study (follow-up) survey question: &quot;In the last 7 days, I took all doses as prescribed&quot; (Response: &quot;strongly agree&quot;)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Patient Participants Who Reported Understanding of Implications of Test Results</measure>
    <time_frame>Post-study (after test results received)</time_frame>
    <description>Post_Study Survey Question: Please indicate your level of agreement with the following statement: &quot;I understood clearly my choices for prevention or early detection of side effects.&quot; (Response: &quot;Sometimes/Often&quot;)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Pharmacist Participants Who Reported Strong Likelihood to Continue to Deliver PGx Testing</measure>
    <time_frame>Post-study (3 months)</time_frame>
    <description>Pharmacist Post-Survey Question: How likely are you to continue providing PGx testing in your pharmacy after the conclusion of the study? (Answer response: &quot;definitely continue&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Score of PGx Knowledge Assessment by Pharmacist Participants</measure>
    <time_frame>Baseline (prior to start of study)</time_frame>
    <description>7-question knowledge assessment of pharmacogenetics. Possible Score Range 0-7; actual range 3-7 (higher scores correspond to higher number of correct answers/higher knowledge)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Pharmacist Participants Who Reported 'Reimbursement' as Most Common Barrier to Delivery of PGx Testing</measure>
    <time_frame>Post-study (3 months)</time_frame>
    <description>Pharmacist Post-Survey Question: Of the following potential barriers to providing PGx testing services, please indicate the greatest perceived barrier (most common response: &quot;reimbursement&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participating Pharmacists Who Feel Qualified to Deliver PGx Testing</measure>
    <time_frame>Post-study (3 months)</time_frame>
    <description>Pharmacist Post-Study survey question: I feel qualified to provide PGx testing at my pharmacy (Answer response: &quot;strongly agree/agree&quot;).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">190</enrollment>
  <condition>Pharmacogenetics</condition>
  <arm_group>
    <arm_group_label>PGx Only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive pharmacogenetic testing. Pharmacists will make recommendations for drug/dose changes based on PGx results.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PGx + MTM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive pharmacogenetic testing along with medication therapy management. Two MTM sessions will be conducted: one at the time testing is ordered and the testing sample is collected, and one when results are returned to the patient. Pharmacists will make recommendations for drug/dose changes based on medication action plan developed during MTM and the PGx results.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medication Therapy Management</intervention_name>
    <description>Community pharmacists will provide medication therapy management in combination with pharmacogenetic testing</description>
    <arm_group_label>PGx + MTM</arm_group_label>
    <other_name>MTM + PGx</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pharmacogenetic testing</intervention_name>
    <description>Community pharmacist will provide pharmacogenetic testing.</description>
    <arm_group_label>PGx + MTM</arm_group_label>
    <arm_group_label>PGx Only</arm_group_label>
    <other_name>PGx</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pharmacist participants must be community pharmacists licensed and practicing in North&#xD;
             Carolina&#xD;
&#xD;
          -  Patient participants must be prescribed one of the 10 eligible medications&#xD;
             (aripiprazole, carisoprodol, celecoxib, citalopram, clopidogrel, metoprolol,&#xD;
             nortriptyline, paroxetine, simvastatin, warfarin)&#xD;
&#xD;
          -  Patient participants must be able to consent to participating and testing on their&#xD;
             own, and be able to read English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who have previously undergone pharmacogenetic testing will not be eligible.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>October 17, 2016</study_first_submitted>
  <study_first_submitted_qc>October 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 18, 2016</study_first_posted>
  <results_first_submitted>April 12, 2021</results_first_submitted>
  <results_first_submitted_qc>May 10, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 3, 2021</results_first_posted>
  <last_update_submitted>May 10, 2021</last_update_submitted>
  <last_update_submitted_qc>May 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 14, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/45/NCT02937545/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Enrolled 154 patient participants and 36 pharmacist participants for a total of 190. Patients and pharmacists were assigned to the PGx only or PGx + MTM study arm.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>PGx Only (Patients)</title>
          <description>Patients received pharmacogenetic testing only. Participating pharmacist made recommendations for drug/dose changes based on PGx results. Data collected from both patients and pharmacists.</description>
        </group>
        <group group_id="P2">
          <title>PGx + MTM (Patients)</title>
          <description>Patients received pharmacogenetic testing along with medication therapy management (MTM). Two MTM sessions will be conducted: one at the time testing is ordered and the testing sample is collected, and one when results are returned to the patient. Pharmacists made recommendations for drug/dose changes based on medication action plan developed during MTM and the PGx results. Data collected from both patients and pharmacists.&#xD;
Medication Therapy Management: Community pharmacists will provide medication therapy management in combination with pharmacogenetic testing</description>
        </group>
        <group group_id="P3">
          <title>PGx Only (Pharmacists)</title>
          <description>Patients received pharmacogenetic testing only. Participating pharmacist made recommendations for drug/dose changes based on PGx results. Data collected from both patients and pharmacists.</description>
        </group>
        <group group_id="P4">
          <title>PGx + MTM (Pharmacists)</title>
          <description>Patients received pharmacogenetic testing plus medication therapy management (MTM). Participating pharmacist made recommendations for drug/dose changes based on PGx results and conducted MTM. Data collected from both patients and pharmacists.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="69"/>
                <participants group_id="P2" count="85"/>
                <participants group_id="P3" count="15"/>
                <participants group_id="P4" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="67"/>
                <participants group_id="P2" count="83"/>
                <participants group_id="P3" count="9"/>
                <participants group_id="P4" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participating patients who completed the study. No baseline data collected for participating pharmacists.</population>
      <group_list>
        <group group_id="B1">
          <title>PGx Only (Patients)</title>
          <description>Patients will receive pharmacogenetic testing. Pharmacists will make recommendations for drug/dose changes based on PGx results.&#xD;
Pharmacogenetic testing: Community pharmacist will provide pharmacogenetic testing.</description>
        </group>
        <group group_id="B2">
          <title>PGx + MTM (Patients)</title>
          <description>Patients will receive pharmacogenetic testing along with medication therapy management. Two MTM sessions will be conducted: one at the time testing is ordered and the testing sample is collected, and one when results are returned to the patient. Pharmacists will make recommendations for drug/dose changes based on medication action plan developed during MTM and the PGx results.&#xD;
Medication Therapy Management: Community pharmacists will provide medication therapy management in combination with pharmacogenetic testing&#xD;
Pharmacogenetic testing: Community pharmacist will provide pharmacogenetic testing.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="67"/>
            <count group_id="B2" value="83"/>
            <count group_id="B3" value="150"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="83"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.3" lower_limit="20" upper_limit="84"/>
                    <measurement group_id="B2" value="64.2" lower_limit="23" upper_limit="91"/>
                    <measurement group_id="B3" value="61.1" lower_limit="20" upper_limit="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="89"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="135"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                    <measurement group_id="B2" value="83"/>
                    <measurement group_id="B3" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Patient Participants' Acceptance of PGx Services Offered in Community Pharmacy Setting</title>
        <description>Post-Study Survey question: &quot;Now that you know your test results, would you have taken the test in the first place?&quot; (Response: 'would definitely' have taken the test)</description>
        <time_frame>Post-study Survey (after test results received)</time_frame>
        <population>Participants who completed the pre/post-study surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>PGx Only (Patients)</title>
            <description>Received pharmagenetic (PGx) testing from the pharmacist and no additional services (related to the study).</description>
          </group>
          <group group_id="O2">
            <title>PGx + MTM (Patients)</title>
            <description>Received pharmacogenetic (PGx) testing plus medication therapy management (MTM)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patient Participants' Acceptance of PGx Services Offered in Community Pharmacy Setting</title>
          <description>Post-Study Survey question: &quot;Now that you know your test results, would you have taken the test in the first place?&quot; (Response: 'would definitely' have taken the test)</description>
          <population>Participants who completed the pre/post-study surveys.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Patient Participants Who Recalled All Test Results</title>
        <description>Post-Study Survey Question: &quot;As best you can, please choose the result of your drug response test for the following genes&quot; (Response: Result selected for all 5 genes)</description>
        <time_frame>Post-study (after test results received)</time_frame>
        <population>Participants who completed the pre/post-study surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>PGx Only (Patients)</title>
            <description>Received pharmagenetic (PGx) testing from the pharmacist and no additional services (related to the study).</description>
          </group>
          <group group_id="O2">
            <title>PGx + MTM (Patients)</title>
            <description>Received pharmacogenetic (PGx) testing plus medication therapy management (MTM)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patient Participants Who Recalled All Test Results</title>
          <description>Post-Study Survey Question: &quot;As best you can, please choose the result of your drug response test for the following genes&quot; (Response: Result selected for all 5 genes)</description>
          <population>Participants who completed the pre/post-study surveys.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Patient Participants Who Considered Time With Pharmacist to be Worthwhile</title>
        <description>Patient survey question - &quot;Did you feel your time spent with the pharmacist was worthwhile?&quot;. Reported as number of participants who selected answer choice &quot;Yes, definitely&quot;.</description>
        <time_frame>Post-study (after test results received)</time_frame>
        <population>Participants who completed the pre/post-study surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>PGx Only (Patients)</title>
            <description>Received pharmagenetic (PGx) testing from the pharmacist and no additional services (related to the study).</description>
          </group>
          <group group_id="O2">
            <title>PGx + MTM (Patients)</title>
            <description>Received pharmacogenetic (PGx) testing plus medication therapy management (MTM)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patient Participants Who Considered Time With Pharmacist to be Worthwhile</title>
          <description>Patient survey question - &quot;Did you feel your time spent with the pharmacist was worthwhile?&quot;. Reported as number of participants who selected answer choice &quot;Yes, definitely&quot;.</description>
          <population>Participants who completed the pre/post-study surveys.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Patient Participants' With High Medication Adherence</title>
        <description>Pre-study (baseline) survey question: &quot;In the last 7 days, I took all doses as prescribed&quot; (Response: &quot;strongly agree&quot;)</description>
        <time_frame>Baseline (prior to testing)</time_frame>
        <population>Participants who completed the pre/post-study surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>PGx Only (Patients)</title>
            <description>Received pharmagenetic (PGx) testing from the pharmacist and no additional services (related to the study).</description>
          </group>
          <group group_id="O2">
            <title>PGx + MTM (Patients)</title>
            <description>Received pharmacogenetic (PGx) testing plus medication therapy management (MTM)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patient Participants' With High Medication Adherence</title>
          <description>Pre-study (baseline) survey question: &quot;In the last 7 days, I took all doses as prescribed&quot; (Response: &quot;strongly agree&quot;)</description>
          <population>Participants who completed the pre/post-study surveys.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Patient Participants With High Medication Adherence (Post-study)</title>
        <description>Post-study (follow-up) survey question: &quot;In the last 7 days, I took all doses as prescribed&quot; (Response: &quot;strongly agree&quot;)</description>
        <time_frame>Post-Study (after test results received)</time_frame>
        <population>Participants who completed the pre/post-study surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>PGx Only (Patients)</title>
            <description>Received pharmagenetic (PGx) testing from the pharmacist and no additional services (related to the study).</description>
          </group>
          <group group_id="O2">
            <title>PGx + MTM (Patients)</title>
            <description>Received pharmacogenetic (PGx) testing plus medication therapy management (MTM)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patient Participants With High Medication Adherence (Post-study)</title>
          <description>Post-study (follow-up) survey question: &quot;In the last 7 days, I took all doses as prescribed&quot; (Response: &quot;strongly agree&quot;)</description>
          <population>Participants who completed the pre/post-study surveys.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Patient Participants Who Reported Understanding of Implications of Test Results</title>
        <description>Post_Study Survey Question: Please indicate your level of agreement with the following statement: &quot;I understood clearly my choices for prevention or early detection of side effects.&quot; (Response: &quot;Sometimes/Often&quot;)</description>
        <time_frame>Post-study (after test results received)</time_frame>
        <population>Participants who completed the pre/post-study surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>PGx Only (Patients)</title>
            <description>Received pharmagenetic (PGx) testing from the pharmacist and no additional services (related to the study).</description>
          </group>
          <group group_id="O2">
            <title>PGx + MTM (Patients)</title>
            <description>Received pharmacogenetic (PGx) testing plus medication therapy management (MTM)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patient Participants Who Reported Understanding of Implications of Test Results</title>
          <description>Post_Study Survey Question: Please indicate your level of agreement with the following statement: &quot;I understood clearly my choices for prevention or early detection of side effects.&quot; (Response: &quot;Sometimes/Often&quot;)</description>
          <population>Participants who completed the pre/post-study surveys.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Pharmacist Participants Who Reported Strong Likelihood to Continue to Deliver PGx Testing</title>
        <description>Pharmacist Post-Survey Question: How likely are you to continue providing PGx testing in your pharmacy after the conclusion of the study? (Answer response: &quot;definitely continue&quot;)</description>
        <time_frame>Post-study (3 months)</time_frame>
        <population>Pharmacists who completed the survey.</population>
        <group_list>
          <group group_id="O1">
            <title>PGx Only (Pharmacists)</title>
            <description>Pharmacists delivered PGx only tests to eligible/consented patients</description>
          </group>
          <group group_id="O2">
            <title>PGx + MTM (Pharmacists)</title>
            <description>Pharmacists delivered PGx testing with MTM to eligible/consented patients</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Pharmacist Participants Who Reported Strong Likelihood to Continue to Deliver PGx Testing</title>
          <description>Pharmacist Post-Survey Question: How likely are you to continue providing PGx testing in your pharmacy after the conclusion of the study? (Answer response: &quot;definitely continue&quot;)</description>
          <population>Pharmacists who completed the survey.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Score of PGx Knowledge Assessment by Pharmacist Participants</title>
        <description>7-question knowledge assessment of pharmacogenetics. Possible Score Range 0-7; actual range 3-7 (higher scores correspond to higher number of correct answers/higher knowledge)</description>
        <time_frame>Baseline (prior to start of study)</time_frame>
        <population>All participating pharmacists.</population>
        <group_list>
          <group group_id="O1">
            <title>PGx Only (Pharmacists)</title>
            <description>Pharmacists delivered PGx only tests to eligible/consented patients</description>
          </group>
          <group group_id="O2">
            <title>PGx Plus MTM (Pharmacists)</title>
            <description>Pharmacists delivered PGx testing with MTM to eligible/consented patients</description>
          </group>
        </group_list>
        <measure>
          <title>Average Score of PGx Knowledge Assessment by Pharmacist Participants</title>
          <description>7-question knowledge assessment of pharmacogenetics. Possible Score Range 0-7; actual range 3-7 (higher scores correspond to higher number of correct answers/higher knowledge)</description>
          <population>All participating pharmacists.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.4" lower_limit="4" upper_limit="7"/>
                    <measurement group_id="O2" value="5.3" lower_limit="3" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Pharmacist Participants Who Reported 'Reimbursement' as Most Common Barrier to Delivery of PGx Testing</title>
        <description>Pharmacist Post-Survey Question: Of the following potential barriers to providing PGx testing services, please indicate the greatest perceived barrier (most common response: &quot;reimbursement&quot;)</description>
        <time_frame>Post-study (3 months)</time_frame>
        <population>Pharmacists who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>PGx Only (Pharmacists)</title>
            <description>Pharmacists delivered PGx only tests to eligible/consented patients</description>
          </group>
          <group group_id="O2">
            <title>PGx + MTM (Pharmacists)</title>
            <description>Pharmacists delivered PGx testing with MTM to eligible/consented patients</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Pharmacist Participants Who Reported 'Reimbursement' as Most Common Barrier to Delivery of PGx Testing</title>
          <description>Pharmacist Post-Survey Question: Of the following potential barriers to providing PGx testing services, please indicate the greatest perceived barrier (most common response: &quot;reimbursement&quot;)</description>
          <population>Pharmacists who completed the study.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participating Pharmacists Who Feel Qualified to Deliver PGx Testing</title>
        <description>Pharmacist Post-Study survey question: I feel qualified to provide PGx testing at my pharmacy (Answer response: &quot;strongly agree/agree&quot;).</description>
        <time_frame>Post-study (3 months)</time_frame>
        <population>Pharmacists who completed the survey.</population>
        <group_list>
          <group group_id="O1">
            <title>PGx Only (Pharmacists)</title>
            <description>Pharmacists delivered PGx only tests to eligible/consented patients</description>
          </group>
          <group group_id="O2">
            <title>PGx + MTM (Pharmacists)</title>
            <description>Pharmacists delivered PGx testing with MTM to eligible/consented patients</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participating Pharmacists Who Feel Qualified to Deliver PGx Testing</title>
          <description>Pharmacist Post-Study survey question: I feel qualified to provide PGx testing at my pharmacy (Answer response: &quot;strongly agree/agree&quot;).</description>
          <population>Pharmacists who completed the survey.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Data collected from enrollment through 6 months follow-up.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>PGx Only (Patients)</title>
          <description>Patients will receive pharmacogenetic testing. Pharmacists will make recommendations for drug/dose changes based on PGx results.&#xD;
Pharmacogenetic testing: Community pharmacist will provide pharmacogenetic testing.</description>
        </group>
        <group group_id="E2">
          <title>PGx + MTM (Patients)</title>
          <description>Patients will receive pharmacogenetic testing along with medication therapy management. Two MTM sessions will be conducted: one at the time testing is ordered and the testing sample is collected, and one when results are returned to the patient. Pharmacists will make recommendations for drug/dose changes based on medication action plan developed during MTM and the PGx results.&#xD;
Medication Therapy Management: Community pharmacists will provide medication therapy management in combination with pharmacogenetic testing&#xD;
Pharmacogenetic testing: Community pharmacist will provide pharmacogenetic testing.</description>
        </group>
        <group group_id="E3">
          <title>PGx Only (Pharmacists)</title>
          <description>Participating pharmacists provided participating patients with pharmacogenetic testing only</description>
        </group>
        <group group_id="E4">
          <title>PGx + MTM (Pharmacists)</title>
          <description>Participating pharmacists provided participating patients with pharmacogenetic testing along with medication therapy management (MTM)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Susanne B Haga</name_or_title>
      <organization>Duke University School of Medicine</organization>
      <phone>919-684-0325</phone>
      <email>susanne.haga@duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

